Interview: Ronan Quinn – CEO, Ardmac, Ireland
Ronan Quinn, CEO of Ardmac, an international provider of high-tech cleanroom facilities to the life sciences sector, tells us the inspiring story of Ardmac’s continued growth through the recent economic…
Ardmac is an international company specialising in the construction of high value working environments for global brands. We retain our market leading position through the skills of our people, the quality of our processes and the sharing of our in-depth industry knowledge.
We specialise in constructing quality interior space for the fit out and refurbishment market as well as cleanroom and controlled environments for research and manufacturing facilities.
Operating through our office network across Ireland, the UK and Benelux region, with business partnerships in the USA and Asia, we employ over 150 staff, providing Ardmac with the global capability to deliver projects to the highest standards for local and international businesses.
Address: Ardmac Limited, Swords Business Campus, Co. Dublin, Ireland
Tel.: +353 1 894 8800
Website: http://www.ardmac.com/
Email: info@ardmac.com
Ronan Quinn, CEO of Ardmac, an international provider of high-tech cleanroom facilities to the life sciences sector, tells us the inspiring story of Ardmac’s continued growth through the recent economic…
This interview also features the comments of Brendan Fitzpatrick, Vice President Finished Goods Manufacturing. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that LEO…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
To what extent do you believe Ireland has been successful in building the knowledge economy it set out to create during the 1980’s? I think we have been hugely successful—and…
You noted that, in the ‘old days’, the pharma business had the following characteristics: first of all, it was a molecule-driven business, fueled by blockbuster medicines that met robust medical…
Dr. McLoughlin, you were appointed to your post in April of this year. Can you please give us an impression of what you inherited at this Department when you took…
Dr. Duffy, how has Pfizer’s investment in Ireland evolved over time? Pfizer began operating in Ireland in the late 1960’s, making citric acid which is an ingredient that can be…
Dr. Mitchell, what attracted you to join Novartis after a decades-long career at Astrazeneca? If you had told me a year ago that I would leave the company I’d worked…
Mr. Zimmermann, you came to manage the Irish affiliate of Bayer in 2010, after heading Business Management for Bayer Pharma Headquarters in Berlin. After these two years, what are your…
Prof. Ferguson, when you were recently appointed to direct SFI, local newspapers ran headlines such as “New SFI head to drive economic impact from research investments.” What do you understand…
Mr. Timmons, when we interviewed your colleague at Takeda Products Ireland, Mr. Kieran Leahy, he mentioned that you have a very interesting professional history. Can you begin by telling us…
Mr. Leahy, you worked for Servier for nearly a decade before joining Takeda. What have been the chief differences you have noticed between the smaller, independent, French player, and the…
See our Cookie Privacy Policy Here
